Teyi Pharmaceutical Group (002728.SZ) has accumulated a repurchase of 2.48% of shares, costing 93.9418 million yuan.
Te Yi Pharmaceutical (002728.SZ) announced that as of February 28, 2025, the company will be traded through centralized bidding...
Teyi Pharmaceutical Group (002728.SZ) announced that as of February 28, 2025, the company repurchased 12.7296 million shares of its own stock through centralized bidding, representing 2.48% of the company's current total share capital. The total amount paid was RMB 93.9418 million (excluding related transaction costs).
Related Articles

US Stock Market Move | Baidu Inc Sponsored ADR Class A (BIDU.US) rose nearly 6%, with institutions predicting that total capital spending on global CSPs will exceed $600 billion by 2026.

LIANLIAN (02598) spent HK$1.631 million on November 6 to repurchase 200,000 shares.
.png)
MELCO INT'L DEV (00200): In the third quarter, net revenue attributable to Melco Resorts & Entertainment was 74.7 million US dollars, a year-on-year increase of 174%.
US Stock Market Move | Baidu Inc Sponsored ADR Class A (BIDU.US) rose nearly 6%, with institutions predicting that total capital spending on global CSPs will exceed $600 billion by 2026.

LIANLIAN (02598) spent HK$1.631 million on November 6 to repurchase 200,000 shares.

MELCO INT'L DEV (00200): In the third quarter, net revenue attributable to Melco Resorts & Entertainment was 74.7 million US dollars, a year-on-year increase of 174%.
.png)
RECOMMEND

SERES Faces Market Test in Hong Kong: Shares Open Below Issue Price Despite HK$220 Billion Market Valuation
06/11/2025

Copper Prices Surge While Former “Copper King” Who Outpaced Huawei and Tencent Falls into Decline
06/11/2025

National Energy Administration Reports New-Type Energy Storage Capacity Exceeds 100 Million Kilowatts by End‑September
06/11/2025


